News

LMO2 is an intrinsically disordered transcription factor activated in T cell leukaemia that is difficult to target. It forms part of a multiprotein complex that has bipartite DNA binding through ...
Stem cells differentiated into brain and neural organoids may help scientists understand both brain development and ...
A groundbreaking study by researchers from the Universities of Basel and Zurich has unlocked one of the most significant ...
STUTTGART, Germany I July 30, 2025 I La Merie Publishing released its newest product entitled: Glypican-3 (GPC3) Targeted Therapy: a Competitor Analysis.
Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...
Like AI, cells change and learn from experience, while unlike computer chips they arrive naturally preprogrammed ...
Scientists in Switzerland have cracked open a century-old viral mystery by decoding the genome of the 1918 influenza virus ...
Scientists have decoded the Swiss genome of the 1918 flu virus from a century-old specimen, revealing early adaptations for human infection. Scientists from the Universities of Basel and Zurich have s ...
Mariam albatoul Reslan “Genes are a powerful tool for unlocking the mysteries of human health and disease.” To begin with, ...